Event chart CARDINAL HEALTH, INC. |
|
|
Upcoming events on CARDINAL HEALTH, INC. |
|
05/25/22 | 08:30am | | UBS Global Healthcare Conference |
06/30/22 | | Ex-dividend day for |
08/03/22 | | FY 2022 Earnings Release (Projected) |
11/10/22 | | Q1 2023 Earnings Release (Projected) |
02/09/23 | | Interim 2023 Earnings Release (Projected) |
05/04/23 | | Q3 2023 Earnings Release (Projected) |
|
Past events on CARDINAL HEALTH, INC. |
|
05/05/22 | 08:30am | | Q3 2022 Earnings Call |
05/05/22 | 06:55am | | Q3 2022 Earnings Release |
03/31/22 | | Ex-dividend day for |
02/03/22 | 08:30am | | Interim 2022 Earnings Call |
02/03/22 | 06:55am | | Interim 2022 Earnings Release |
01/10/22 | 10:30am | | JP Morgan Healthcare Conference |
12/31/21 | | Ex-dividend day for |
11/10/21 | 10:30am | | Credit Suisse Healthcare Conference |
11/09/21 | 08:30am | | Q1 2022 Earnings Call |
11/09/21 | 06:55am | | Q1 2022 Earnings Release |
|
Past dividends on CARDINAL HEALTH, INC. |
|
03/31/22 | | Quarterly 0.4908 USD |
12/31/21 | | Quarterly 0.4908 USD |
09/30/21 | | Quarterly 0.4908 USD |
06/30/21 | | Quarterly 0.4908 USD |
03/31/21 | | Quarterly 0.4859 USD |
12/31/20 | | Quarterly 0.4859 USD |
09/30/20 | | Quarterly 0.4859 USD |
06/30/20 | | Quarterly 0.4859 USD |
03/31/20 | | Quarterly 0.4811 USD |
12/31/19 | | Quarterly 0.4811 USD |
|
|
Fiscal Period : June | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M $ |
Released Forecast Spread | 129 976 129 703 0,21% | 136 809 135 824 0,73% | 145 534 144 857 0,47% | 152 922 153 166 -0,16% | 162 467 160 257 1,4% | 178 329 |
Operating income (EBITDA) M $ |
Released Forecast Spread | 2 959 3 060 -3,3% | 2 910 3 062 -5,0% | 2 732 2 760 -1,0% | 2 773 2 756 0,62% | 2 587 2 843 -9,0% | 2 433 |
Operating profit (EBIT) M $ |
Released Forecast Spread | 2 769 2 812 -1,5% | 2 585 2 648 -2,4% | 2 353 2 345 0,33% | 2 384 2 361 0,97% | 2 255 2 474 -8,9% | 2 019 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread |
| -228 1 282 -118% | 1 751 1 572 11% | -3 772 -4 386 14% | 323 1 146 -72% | -634 |
Net income M $ |
Released Forecast Spread | 1 288 1 356 -5,0% | 256 1 468 -83% | 1 363 1 226 11% | -3 696 -4 213 12% | 611 652 -6,3% | -975 |
EPS $ |
Released Forecast Spread | 4,03 4,14 -2,7% | 0,81 4,96 -84% | 4,53 4,55 -0,37% | -12,6 -14,3 12% | 2,08 2,21 -6,1% | -3,53 | Announcement Date | 08/02/2017 | 08/06/2018 | 08/08/2019 | 08/06/2020 | 08/05/2021 | - |
|
|
Fiscal Period : June | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
Sales M $ |
Released Forecast Spread | 39 157 37 042 5,7% | 36 689 36 818 -0,35% | 39 065 38 142 2,4% | 41 541 41 438 0,25% | 39 275 40 177 -2,2% | 42 586 40 219 5,9% | 43 968 41 826 5,1% | 45 457 45 342 0,25% | 44 836 43 199 3,8% | 44 953 | 46 104 | 47 751 | 46 411 | 47 463 |
Operating income (EBITDA) M $ |
Released Forecast Spread | 813 769 5,7% | 538 522 3,2% | 705 599 18% | 711 719 -1,1% | 777 779 -0,26% | 394 648 -39% | 616 647 -4,9% | 552 582 -5,2% | 726 687 5,7% | 585 | 593 | 622 | 725 | 629 |
Operating profit (EBIT) M $ |
Released Forecast Spread | 719 630 14% | 442 418 5,7% | 618 496 25% | 628 618 1,6% | 689 689 0,05% | 320 548 -42% | 527 555 -5,1% | 467 495 -5,7% | 545 606 -10% | 479 | 514 | 524 | 624 | 509 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | 478 372 28% | 815 201 305% | -663 302 -320% | 427 428 -0,21% | 440 501 -12% | 119 367 -68% | 369 414 -11% | -973 400 -343% | -137 471 -129% | 312 | 326 | 340 | 409 | 293 |
Net income M $ |
Released Forecast Spread | 350 298 18% | 656 160 309% | -253 246 -203% | 629 390 61% | 119 362 -67% | 116 157 -26% | 271 278 -2,7% | 49,0 251 -80% | -1 391 281 -596% | 245 | 196 | 209 | 279 | 185 |
EPS $ |
Released Forecast Spread | 1,19 1,07 11% | 2,23 0,54 310% | -0,86 0,80 -208% | 2,13 1,27 67% | 0,40 1,18 -66% | 0,40 0,54 -26% | 0,94 1,00 -6,1% | 0,17 0,96 -82% | -5,05 1,14 -543% | 0,90 | 0,73 | 0,79 | 1,07 | 0,72 | Announcement Date | 05/11/2020 | 08/06/2020 | 11/05/2020 | 02/05/2021 | 05/06/2021 | 08/05/2021 | 11/09/2021 | 02/03/2022 | 05/05/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for CARDINAL HEALTH, INC. |
|
|
|
Past sector events for CARDINAL HEALTH, INC. |
|
|
|
|
|
|
U.S. should review drugmakers' opioid settlement tax breaks - House panel |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|